Patents by Inventor James Cusack

James Cusack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systemic purine administration: modulating axonal outgrowth of central nervous system neurons
    Patent number: 8133861
    Abstract: Methods for modulating the axonal outgrowth of central nervous system neurons are provided by means of internalized purine administration such as by intravenous, intraarterial, subcutaneous, intramuscular, intraperitoneal, and intrapleural administration. The methods are noted for stimulating the axonal outgrowth of central nervous system neurons following an injury (e.g., stroke, traumatic brain injury, cerebral aneurism, spinal cord injury and the like).
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: March 13, 2012
    Assignee: Alseres Pharmaceuticals, Inc.
    Inventors: Noel James Cusack, Mark R. Hurtt, Richard M. Thorn
  • CHIMERIC C3-LIKE RHO ANTAGONIST BONE THERAPEUTIC
    Publication number: 20090252712
    Abstract: Methods of treating bone disorders in a subject in need thereof by administering to said subject a therapeutically effective amount of a Rho antagonist are disclosed.
    Type: Application
    Filed: March 9, 2009
    Publication date: October 8, 2009
    Applicant: Alseres Pharmaceuticals, Inc.
    Inventors: Noel James Cusack, Jon Scott Munzer
  • SYSTEMIC PURINE ADMINISTRATION: MODULATING AXONAL OUTGROWTH OF CENTRAL NERVOUS SYSTEM NEURONS
    Publication number: 20090221521
    Abstract: Methods for modulating the axonal outgrowth of central nervous system neurons are provided by means of internalized purine administration such as by intravenous, intraarterial, subcutaneous, intramuscular, intraperitoneal, and intrapleural administration. The methods are noted for stimulating the axonal outgrowth of central nervous system neurons following an injury (e.g., stroke, traumatic brain injury, cerebral aneurism, spinal cord injury and the like).
    Type: Application
    Filed: February 26, 2009
    Publication date: September 3, 2009
    Applicant: Alseres Pharmaceuticals, Inc.
    Inventors: Mark R. Hurtt, Noel James Cusack, Richard M. Thorn
  • Use of NF-kB Inhibition in Combination Therapy for Cancer
    Publication number: 20070110828
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Application
    Filed: September 27, 2006
    Publication date: May 17, 2007
    Inventors: Albert Baldwin, James Cusack, Marty Mayo, Cun-Yu Wang
  • Use of NF-kB Inhibition in Combination Therapy for Cancer
    Publication number: 20070105751
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Application
    Filed: September 27, 2006
    Publication date: May 10, 2007
    Inventors: Albert Baldwin, James Cusack, Marty Mayo, Cun-Yu Wang
  • Use of NF-kB inhibition in combination therapy for cancer
    Publication number: 20050123506
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Application
    Filed: November 2, 2004
    Publication date: June 9, 2005
    Inventors: Albert Baldwin, James Cusack, Marty Mayo, Cun-Yu Wang